-+ 0.00%
-+ 0.00%
-+ 0.00%

Aprea Therapeutics Expands Current Patent Portfolio

Benzinga·08/28/2026 12:17:01
Listen to the news

Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers, today provided an update on its existing patent portfolio.